TL;DR
A new application of CAR T cell therapy, originally developed for cancer, is showing promising results in clinical trials for autoimmune diseases. Early data suggest it can potentially reset immune responses, but long-term effects remain uncertain. This development could transform treatment options for conditions like multiple sclerosis and lupus.
Recent clinical trials indicate that CAR T cell therapy, initially designed for cancer, is showing promising results as a potential treatment for autoimmune diseases such as multiple sclerosis and lupus. Early data suggest the therapy can reset the immune system, potentially offering a new approach to managing these chronic conditions. This development matters because it could lead to highly effective, long-lasting treatments for millions affected worldwide.
Researchers at the University of Nebraska Medical Center and other institutions have begun testing CAR T cell therapy for autoimmune diseases, with early trials indicating significant improvements. For example, a patient with multiple sclerosis, Jan Janisch-Hanzlik, received the experimental treatment in June 2025 after conventional medications failed to control her symptoms. Her case exemplifies the therapy’s potential to eliminate problematic immune cells that attack the body’s own tissues.
CAR T therapy was originally approved by the FDA in 2017 for certain blood cancers, where it activates T cells to target malignant B cells. Scientists are now adapting this technology to target the B cells responsible for producing harmful antibodies in autoimmune diseases. Preliminary results from trials in conditions like lupus and stiff person syndrome show that many patients experience reduced symptoms and decreased reliance on immunosuppressive drugs, with some regaining mobility and independence.
Why It Matters
This development could revolutionize treatment for autoimmune diseases, which currently rely heavily on lifelong immunosuppression with limited success and significant side effects. If proven effective and safe long-term, CAR T therapy could offer a one-time treatment that resets the immune system, potentially providing lasting remission and improving quality of life for millions worldwide.
CAR T: A New Cure for Cancer, Autoimmune and Inherited Disease
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Background
CAR T cell therapy was first approved for certain blood cancers in 2017, with subsequent expansion into other oncology indications. The concept of repurposing it for autoimmune diseases gained traction after a German team reported positive results in lupus patients in 2021. Since then, multiple clinical trials have been launched, including studies on conditions like multiple sclerosis, lupus, vasculitis, and stiff person syndrome. Early findings suggest that targeting B cells with modified T cells can reduce disease activity, but long-term data are still lacking.
“I think it’s a game changer for autoimmune treatment options.”
— Amanda Piquet, autoimmune neurologist at the University of Colorado
“I felt hope and fear, knowing the risks but also the possibility of a new life.”
— Jan Janisch-Hanzlik, MS patient
Autoimmune Disease Anti-Inflammatory Diet: Simple Steps To Lifetime Relief
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
What Remains Unclear
It is still unclear how durable the benefits of CAR T therapy will be for autoimmune diseases, and long-term safety data are lacking. There are also questions about potential side effects, such as immune overactivation or other unforeseen complications, which require further investigation in ongoing and future trials.
The Inflammation Spectrum: Find Your Food Triggers and Reset Your System
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
What’s Next
Next steps include larger, controlled clinical trials to confirm efficacy and safety, along with long-term follow-up to assess durability of remission and potential risks. Regulatory agencies will need to evaluate new data before broader approval for autoimmune indications can be considered.
My Autoimmune Health Diary: Symptoms & Pain Tracker
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
How does CAR T cell therapy work for autoimmune diseases?
It involves engineering a patient’s T cells to target and eliminate B cells that produce harmful antibodies, aiming to reset the immune system and reduce disease activity.
What are the risks associated with this treatment?
Possible risks include immune overactivation, inflammation, and unknown long-term side effects. These are still being studied in ongoing trials.
When might this treatment become widely available?
If ongoing trials confirm safety and efficacy, regulatory approval could take several years, with broader availability potentially within the next 5-10 years.
Can CAR T therapy cure autoimmune diseases?
It is too early to say whether it can cure these conditions, but early results suggest it may significantly reduce symptoms and possibly induce long-term remission.
